Efficacy and safety of tianeptine in the treatment of depressive disorders in comparison with fluoxetine

Journal of Affective Disorders

Volumn 56, Issue 2-3, 1999, Pages 109-118

  Loo H ^a   Saiz Ruiz, J ^b   Costa E Silva, J A ^c   Ansseau, M ^d   Herrington, R ^e   Vaz Serra, A ^f   Dilling, H ^g   De Risio, S ^h  

^a CENTRE HOSPITALIER SAINTE ANNE   (France)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c University Hospital   (Brazil)

^d UNIVERSITY OF LIÈGE   (Belgium)

^e GARTNAVEL ROYAL HOSPITAL   (United Kingdom)

^f CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^g UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^h CATHOLIC UNIVERSITY   (Italy)

Author keywords

Depressive Disorders; Fluoxetine; Tianeptine

Indexed keywords

ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; CLORAZEPATE; FLUOXETINE; OXAZEPAM; PLACEBO; SEROTONIN UPTAKE INHIBITOR; TIANEPTINE;

ADULT; ARTHRALGIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ECZEMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALAISE; MALE; MANIC DEPRESSIVE PSYCHOSIS; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SUICIDE ATTEMPT; VERTIGO;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; FEMALE; FLUOXETINE; HUMANS; MALE; MIDDLE AGED; THIAZEPINES; TREATMENT OUTCOME;

EID: 0342879918     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(99)00009-9     Document Type: Article

References (30)

1. ®). Ann. Psychiatrie. 8:(2):1993;136-144.
2. Bobon D.P. Le système AMDP. in. Psycho. Sci. Hum. 2e éd. coll :1981;Mardaga, Bruxelles.
3. Chamba G., Lemoine P., Flachaire E., Ferry N., Quincy C., Sassard J., Ferber C., Mocaër E., Kamoun A., Renaud B. Increased serotonin platelet uptake after tianeptine administration in depressed patients. Biol. Psychiatry. 30:1991;609-617.
4. Chapuy P., Cuny G., Delomier Y., Galley P., Michel J.P., Pareaud M., Marey C. La dépression du sujet âgé. Íntérât de la tianeptine chez 140 patients traités pendant un an. Presse Med. 20:(37):1991;1844-1852.
5. Delalleau B., Dulcire C., Le Moine P., Kamoun A. Analysis of the side-effects of tianeptine. Clin. Neuropharmacol. 11:(suppl 2):1988;S83-S89.
6. Faravelli C., Servi P., Arends J.A., Strik W.K. Number of symptoms, Quantification, and Qualification of Depression. Compr. Psychiatry. 37:(5):1996;307-315.
7. Gross G., Huber G. Depressive or Mood Disorders in Operationalized Classification Systems and the Affective Psychoses (Manic-Depressive Illness, Cyclothymia) of the Traditional Psychiatry. A critical review. Neurology, Psychiatry and Brain Res. 4:1996;149-158.
8. Guelfi J.D. Efficacy of tianeptine in comparative trials versus reference antidepressants: an overview. Br. J. Psychiatry. 160:(suppl 15):1992;72-75.
9. Guelfi J.D., Dulcire C., Le Moine P., Tafani A. Clinical safety and efficacy of tianeptine in 1858 depressed patients treated in general practice. Neuropsychobiology. 25:1992;140-148.
10. Guelfi J.D., Pichot P., Dreyfus J.F. Efficacy of tianeptine in anxious-depressed patients: Results of a controlled multicenter trial versus amitriptyline. Neuropsychobiology. 22:1989;41-48.
11. Hamdi E., Amin Y., Abou-Saleh M.T. Problems in validating endogenous depression in the Arab culture by contemporary diagnostic criteria. J. Affect. Disord. 44:1997;131-143.
12. Hiller W., Dichtl G., Hecht H., Hundt W., Mombourg W., von Zerssen D. Evaluating the new ICD-10 categories of depressive episode and recurrent depressive disorder. J. Affect. Disord. 31:1994;49-60.
13. Invernizzi G., Aguglia E., Bertolino A., Casacchia M., Ciani N., Marchesi G.F., Nardini M., Rapisarda V. The efficacy and safety of tianeptine in the treatment of depressive disorder: results of a controlled double-blind multicentre study versus amitriptyline. Neuropsychobiology. 30:1994;85-93.
14. Kato G., Weitsch A.F. Neurochemical profile of tianeptine a new antidepressant drug. Clinical Neuropharmacology. 11:(suppl 2):1988;S43-S50.
15. Kelly J.P., Leonard B.E. The effect of tianeptine on the olfactory bulbectomized (OB) rat model of depression. IIIrd International Congress of European Behavioural Pharmacology Meeting, Noordwigkhout (The Netherlands), 25-27 June 1990. Psychopharmacology. 101:(suppl):1990;S28.
16. Lôo H., Malka R., Defrance R., Barrucand D., Benard J.Y., Niox-Rivière H., Raab A., Sarda A., Vachonfrance G., Kamoun A. Tianeptine and amitriptyline: controlled double-blind trial in depressed alcoholic patients. Neuropsychobiology. 19:1988;79-85.
17. Lôo, H., Ganry, H., Marey, C., Briole, G., Castelnau, D., Charbonnier, J.F., Dachary, J.M., Danion, J.M. Darcourt, G., Capdeville, C., Dufour, H., Souche, A., Escande, M., Favre, J.D., Féline, A., Guelfi, J.D., Léger, J.M., Malauzat, D., Lemoine, P., Malka, R., Olié, J.P., de Praingy, M., Scharbach, H., Scotto, J.C., Tignol, J., Kamoun, A., 1990. Acceptabilité et efficacité thérapeutique de la tianeptine chez 510 patients déprimés traités en un an. JAMA 11 (hors série), 44-53.
18. Lôo H., Ganry H., Dufour H., Guelfi J.D., Malka R., Olié J.P., Scharbach H., Tignol J., Marey C., Kamoun A. Long-term use of tianeptine in 380 depressed patients. Br. J. Psychiatry. 160:(suppl 15):1992;61-65.
19. Mennini T., Mocaër E., Garattini S. Tianeptine, a selective enhancer of serotonin uptake in rat brain. Naunyn Schmiedeberg's Arch. Pharmacol. 336:1987;478-482.
20. Mocaër E., Rettori M.C., Kamoun A. Pharmacological antidepressive effects and tianeptine induced 5-HT uptake increase. Clin. Neuropharmacol. 11:(suppl 2):1988;S32-S42.
21. Montgomery S.A. Selective Serotonin Reuptake Inhibitors in the Acute Treatment of Depression. Bloom F.E., Kupfer D.J. Psychopharmacology - The Fourth Generation of Progress. 1995;Raven Press.
22. Montgomery S.A., Asberg M. A new depression scale designed to be sensitive to change. Br. J. Psychiatry. 134:1979;382-389.
23. Ostaptzeff G. Etude contrôlée à double insu versus imipramine de l'efficacité de la tianeptine dans des états dépressifs non psychotiques. Biol. Psychiatry. 5:1981;597-600.
24. Philipp M., Maier W., Delmo C.D. The concept of major depression. I. Descriptive comparison of six competing operational definitions including ICD-10 and DSM-III-R. Eur. Arch. Psychiatry Clin. Neurosci. 1991. 240:1991;258-265.
25. Poignant J.C. Etude pharmacologique d'un nouvel antidépresseur: la tianeptine. Biol. Psychiatry. 5:1981;573-578.
26. Renaud, B., Mocaër, E., Weitsch, A.F., Kato, G., Mennini, T., Garattini, S., 1988. Stimulation of serotonin uptake induced by a new antidepressant. ECNP Constituent meeting, Brussels (Belgium), May 1987, Pharmacopsychiatry 21, 66.
27. Sternbach H. The Serotonin Syndrome. Am. J. Psychiatry. 148:(6):1991;705-713.
28. Thiébot M.H., Martin P., Puech A.J. Animal behavioural studies in the evaluation of antidepressant drugs. Br. J. Psychiatry. 160:(suppl 15):1992;44-50.
29. Weiss C., Gorceix A., Kindynis S., Dimitriu M. Etude contrôlée à double insu versus nomifensine de l'activité et du délai d'action d'un nouvel antidépresseur la tianeptine. Biol. Psychiatry. 5:1981;593-596.
30. Whitton P.S., Sarna G.S., Curzon G. Effects of tianeptine on stress-induced behavioural deficits and 5-HT dependent behaviour. Psychopharmacology. 104:1991;81-85.